{"disease":{"id":"dacomitinib-for-egfr-mutated-non-small-cell-lung-cancer-nsclc-with-brain-metastases","name":"dacomitinib for egfr mutated non small cell lung cancer nsclc with brain metastases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04339829","title":"An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}